|
Mahamaya Lifesciences Ltd.
|
QUARTERLY RESULTS
|
|
|
You can view the
Quaterly Results
for the last 5 years.
|
Market Cap. (Rs.)
|
370.62 Cr.
|
P/BV
|
5.85
|
Book Value (Rs.)
|
27.05
|
|
52 Week High/Low (Rs.)
|
205/111
|
FV/ML
|
10/1200
|
P/E(X)
|
28.63
|
|
Bookclosure
|
|
EPS (Rs.)
|
5.53
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 80.06 | 83.01 |
| Other Operating Income | 0.33 | 0.00 |
| Total Income From Operations | 80.38 | 83.01 |
| | | |
| EXPENDITURE | | |
| Consumption of Raw Materials | -68.85 | 68.85 |
| Purchase of Traded Goods | 171.03 | 0.00 |
| Increase/Decrease in Stocks | -32.36 | 0.71 |
| Employees Cost | 1.92 | 1.96 |
| Depreciation | 0.56 | 0.54 |
| Other Expenses | 0.38 | 4.33 |
| Total Expenses | 72.67 | 76.39 |
| | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 7.71 | 6.62 |
| Other Income | -0.09 | 1.03 |
| P/L Before Interest, Excpt. Items & Tax | 7.62 | 7.65 |
| Interest | 1.89 | 1.96 |
| P/L Before Exceptional Items & Tax | 5.73 | 5.69 |
| P/L Before Tax | 5.73 | 5.69 |
| Tax | 1.46 | 1.59 |
| P/L After Tax from Ordinary Activities | 4.27 | 4.10 |
| Net Profit/Loss For the Period | 4.27 | 4.10 |
| Net P/L After Minority Interest & Share Of Associates | 4.27 | 4.10 |
| | | |
| Equity Share Capital | 17.77 | 17.77 |
| EPS Before Extra Ordinary * | | |
| Basic EPS (Rs.) | 2.40 | 2.31 |
| Diluted EPS (Rs.) | 2.40 | 2.31 |
| EPS After Extra Ordinary * | | |
| Basic EPS (Rs.) | 2.40 | 2.31 |
| Diluted EPS (Rs.) | 1.20 | 2.31 |
| | | |
| PBITOE Margin (%) | 9.58 | 7.97 |
| PBTE Margin (%) | 7.12 | 6.85 |
| PBT Margin (%) | 7.12 | 6.85 |
| PAT Margin (%) | 5.30 | 4.94 |
| PAT After MI And SOA Margin (%) | 5.30 | 4.94 |
